Posted by Michael Wonder on 23 Nov 2019
Santen receives CADTH Canadian Drug Expert Committee reimbursement recommendation for Verkazia (cyclosporin 0.1%) eye drops
22 November 2019 - Santen Canada announced that the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee released a reimbursement recommendation for Verkazia (cyclosporin 0.1%) eye drops.
This reimbursement recommendation marks an important step towards providing patients access to this new formulation of cyclosporine eye drops in Canada.
Provincial jurisdictions are the final decision makers on public reimbursement.
